Anaheim Eye Institute leads the way with Voyager™ DSLT—non-contact, drop-free care that’s changing lives.
For millions living with open-angle glaucoma (OAG) or ocular hypertension (OHT), managing eye pressure means a lifelong routine of medicated eye drops—multiple times a day. These drops can be difficult to apply consistently, come with side effects, and add up in cost over time. But what if glaucoma treatment could be drop-free, pain-free, and contact-free?
At Anaheim Eye Institute, we’re proud to be among the first practices in Orange County to offer the groundbreaking Voyager™ DSLT (Direct Selective Laser Trabeculoplasty). Backed by global clinical studies and leading ophthalmology researchers, this advanced technology represents a major leap forward in non-invasive glaucoma management.
“Imagine treating glaucoma without drops, surgery, or touching the eye. With Voyager™ DSLT, that’s now a reality.”
What Is Voyager™ DSLT?
Voyager™ DSLT is the newest evolution of laser trabeculoplasty, a proven method for lowering intraocular pressure (IOP). But unlike traditional lasers like SLT (Selective Laser Trabeculoplasty), Voyager’s Direct SLT approach delivers 120 ultra-precise pulses through the limbus (the outer edge of the iris)—with no need to contact the eye.
That means:
- No anesthetic drops
- No physical contact
- No post-op medication
- Minimal recovery time
The procedure is fast, comfortable, and typically completed in under 5 minutes per eye. Most patients return to normal activities immediately.
Why Voyager™ DSLT Is a Game-Changer
The LiGHT study, published in The Lancet and widely regarded as a landmark in glaucoma research, confirmed that SLT is as effective as eye drops—but with fewer side effects and better long-term control of IOP. Voyager™ DSLT builds on that science with even more precise delivery and a contact-free experience.
Key advantages include:
- Clinically proven IOP reduction
- Superior safety profile with minimal inflammation risk
- No reliance on patient compliance (unlike drops)
- Ideal first-line treatment for early-stage glaucoma and OHT
- Drop-free and maintenance-free solution for select patients
At Anaheim Eye Institute, we believe in bringing tomorrow’s technology to our patients today—and Voyager DSLT fits seamlessly into that mission.
Who Is a Candidate for Voyager™ DSLT?
This treatment is ideal for:
- Patients with newly diagnosed open-angle glaucoma
- Individuals with ocular hypertension at risk of progression
- Those experiencing side effects or poor compliance with eye drops
- Patients seeking a non-surgical, drop-free option
It may also benefit those who are struggling with physical or cognitive barriers to using daily medication effectively. Our team conducts comprehensive evaluations to determine if Voyager™ DSLT is appropriate, including advanced imaging and pressure testing.
What to Expect from the Procedure
At Anaheim Eye Institute, your comfort and safety come first. Here’s what you can expect:
- A brief consultation and pre-treatment exam
- Painless delivery of laser pulses via an external device
- No post-op medications or restrictions
- Follow-up visit to monitor IOP reduction
Most patients see significant pressure drops within days, with results continuing to stabilize over the following weeks.
And because Voyager™ DSLT is non-destructive, it can be repeated in the future if needed—unlike some surgical procedures.
FAQ: Voyager™ DSLT for Glaucoma
Is DSLT painful?
Not at all. It’s a no-contact, no-touch procedure. Most patients feel nothing beyond mild pressure during treatment.
Will I still need eye drops after DSLT?
Many patients experience significant IOP reduction and can reduce or eliminate drops. Your ophthalmologist will determine the best follow-up care.
How does it compare to traditional SLT?
Voyager™ DSLT offers the same pressure-lowering benefits—but without needing to touch the eye or apply anesthesia.
Is it covered by insurance?
DSLT is considered an advanced form of SLT. Coverage varies by provider. We offer insurance verification and financing options for qualified patients.
